$167 Million is the total value of Iguana Healthcare Management, LLC's 60 reported holdings in Q4 2016. The portfolio turnover from Q3 2016 to Q4 2016 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Exit | ONCOMED PHARMACEUTICALS INCput | $0 | – | -50,000 | -100.0% | -0.10% | – | |
| MEIP | Exit | MEI PHARMA INC | $0 | – | -600,000 | -100.0% | -0.19% | – |
| ESPR | Exit | ESPERION THERAPEUTICS INC NE | $0 | – | -80,000 | -100.0% | -0.20% | – |
| Exit | ESPERION THERAPEUTICS INC NEput | $0 | – | -100,000 | -100.0% | -0.25% | – | |
| EPZM | Exit | EPIZYME INC | $0 | – | -150,000 | -100.0% | -0.26% | – |
| ONCE | Exit | SPARK THERAPEUTICS INC | $0 | – | -25,000 | -100.0% | -0.27% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INC | $0 | – | -50,000 | -100.0% | -0.28% | – |
| PRAH | Exit | PRA HEALTH SCIENCES INC | $0 | – | -30,000 | -100.0% | -0.30% | – |
| THC | Exit | TENET HEALTHCARE CORP | $0 | – | -100,000 | -100.0% | -0.40% | – |
| Exit | GILEAD SCIENCES INCcall | $0 | – | -30,000 | -100.0% | -0.42% | – | |
| MGNX | Exit | MACROGENICS INC | $0 | – | -80,000 | -100.0% | -0.43% | – |
| Exit | FIVE PRIME THERAPEUTICS INCput | $0 | – | -50,000 | -100.0% | -0.47% | – | |
| IVTY | Exit | INVUITY INC | $0 | – | -200,000 | -100.0% | -0.49% | – |
| Exit | PHARMERICA CORPput | $0 | – | -100,000 | -100.0% | -0.50% | – | |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -50,000 | -100.0% | -0.55% | – |
| OPHT | Exit | OPHTHOTECH CORP | $0 | – | -70,000 | -100.0% | -0.58% | – |
| KITE | Exit | KITE PHARMA INC | $0 | – | -60,000 | -100.0% | -0.60% | – |
| ACHC | Exit | ACADIA HEALTHCARE COMPANY IN | $0 | – | -70,000 | -100.0% | -0.62% | – |
| IONS | Exit | IONIS PHARMACEUTICALS INC | $0 | – | -100,000 | -100.0% | -0.65% | – |
| PMC | Exit | PHARMERICA CORP | $0 | – | -150,000 | -100.0% | -0.75% | – |
| BIOS | Exit | BIOSCRIP INC | $0 | – | -1,500,000 | -100.0% | -0.77% | – |
| RTRX | Exit | RETROPHIN INC | $0 | – | -200,000 | -100.0% | -0.80% | – |
| IPXL | Exit | IMPAX LABORATORIES INC | $0 | – | -200,000 | -100.0% | -0.84% | – |
| Exit | AERIE PHARMACEUTICALS INCput | $0 | – | -130,000 | -100.0% | -0.88% | – | |
| FLML | Exit | FLAMEL TECHNOLOGIES SAsponsored adr | $0 | – | -400,000 | -100.0% | -0.88% | – |
| PCRX | Exit | PACIRA PHARMACEUTICALS INC | $0 | – | -150,000 | -100.0% | -0.92% | – |
| Exit | GLOBAL BLOOD THERAPEUTICS INput | $0 | – | -100,000 | -100.0% | -0.94% | – | |
| GWPH | Exit | GW PHARMACEUTICALS PLCads | $0 | – | -40,000 | -100.0% | -0.95% | – |
| Exit | LILLY ELI & COcall | $0 | – | -75,000 | -100.0% | -1.07% | – | |
| Exit | GW PHARMACEUTICALS PLCcall | $0 | – | -50,000 | -100.0% | -1.18% | – | |
| BMY | Exit | BRISTOL MYERS SQUIBB CO | $0 | – | -130,000 | -100.0% | -1.25% | – |
| Exit | BIOGEN INCcall | $0 | – | -25,000 | -100.0% | -1.40% | – | |
| EXEL | Exit | EXELIXIS INC | $0 | – | -700,000 | -100.0% | -1.60% | – |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INC | $0 | – | -150,000 | -100.0% | -1.81% | – |
| SHPG | Exit | SHIRE PLCsponsored adr | $0 | – | -65,000 | -100.0% | -2.25% | – |
| Exit | CELGENE CORPcall | $0 | – | -150,000 | -100.0% | -2.80% | – | |
| PFE | Exit | PFIZER INC | $0 | – | -500,000 | -100.0% | -3.02% | – |
| Exit | GW PHARMACEUTICALS PLCput | $0 | – | -130,000 | -100.0% | -3.08% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOGEN INC | 17 | Q1 2018 | 7.5% |
| ULTRAGENYX PHARMACEUTICAL IN | 17 | Q1 2018 | 6.7% |
| MERCK & CO INC NEW | 16 | Q1 2018 | 5.4% |
| CELGENE CORP | 15 | Q4 2017 | 7.9% |
| AERIE PHARMACEUTICALS INC | 15 | Q4 2017 | 3.3% |
| GILEAD SCIENCES INC | 14 | Q1 2017 | 6.7% |
| ESPERION THERAPEUTICS INC NE | 14 | Q1 2018 | 7.8% |
| SUPERNUS PHARMACEUTICALS INC | 14 | Q4 2017 | 2.8% |
| DERMIRA INC | 14 | Q1 2018 | 2.7% |
| AMGEN INC | 13 | Q1 2017 | 6.5% |
View Iguana Healthcare Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2018-05-15 |
| 13F-HR | 2018-02-14 |
| 13F-HR/A | 2017-11-16 |
| 13F-HR | 2017-11-14 |
| 13F-HR | 2017-08-14 |
| 13F-HR | 2017-05-15 |
| 13F-HR | 2017-02-14 |
| 13F-HR/A | 2016-11-17 |
| 13F-HR | 2016-11-14 |
| 13F-HR/A | 2016-11-04 |
View Iguana Healthcare Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.